/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Altimmune Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$5.06 0.0735(7.35%) ALT at 04 Dec 2025 04:25 PM Biotechnology
Lowest Today 4.71
Highest Today 5.145
Today’s Open 4.82
Prev. Close 4.76
52 Week High 10.11
52 Week Low 2.90
Day’s Range: Low 4.71 High 5.145
52-Week Range: Low 2.90 High 10.11
1 day return -
1 Week return -2.75
1 month return +36.21
3 month return +44.08
6 month return -6.74
1 year return -47.96
3 year return -53.91
5 year return -58.59
10 year return -

Institutional Holdings

BlackRock Inc 7.22

Vanguard Group Inc 5.85

State Street Corp 3.12

TANG CAPITAL MANAGEMENT LLC 3.12

Vanguard Total Stock Mkt Idx Inv 3.09

Geode Capital Management, LLC 2.19

iShares Russell 2000 ETF 2.10

Susquehanna International Group, LLP 1.84

SPDR® S&P Biotech ETF 1.41

Knoll Capital Management LP 1.27

Caption Management, LLC 1.11

Federated Hermes Inc 1.04

UBS Group AG 1.00

Vanguard Institutional Extnd Mkt Idx Tr 1.00

Morgan Stanley - Brokerage Accounts 0.95

Fidelity Small Cap Index 0.88

Bank of America Corp 0.81

iShares Russell 2000 Growth ETF 0.76

Northern Trust Corp 0.73

Federated Hermes MDT SCC Institutional 0.67

Federated Hermes MDT Small Cap Core IS 0.67

Citadel Advisors Llc 0.59

Goldman Sachs Group Inc 0.57

iShares Biotechnology ETF 0.55

Group One Trading, LP 0.53

Dimensional Fund Advisors, Inc. 0.51

Two Sigma Investments LLC 0.50

Fidelity Extended Market Index 0.49

FMR Inc 0.46

Vanguard Russell 2000 ETF 0.42

Fidelity Enhanced Small Cap ETF 0.39

Beirne Wealth Consulting Services, LLC 0.39

Federated Hermes MDT SCG Institutional 0.30

Federated Hermes MDT Small Cap Growth IS 0.30

State St Russell Sm Cap® Indx SL Cl I 0.28

Vanguard Health Care ETF 0.27

Vanguard Explorer Inv 0.22

Schwab Small Cap Index 0.22

NT R2000 Index Fund - NL 0.21

iShares Micro-Cap ETF 0.20

Market Status

Strong Buy: 5

Buy: 3

Hold: 1

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 496.67 M

PB Ratio 2.7716

PE Ratio 0.0

Enterprise Value 319.54 M

Total Assets 139.31 M

Volume 2566364

Company Financials

Annual Revenue FY23:279000 0.3M, FY22:-68000 -0.1M, FY21:4410356 4.4M, FY20:8185027 8.2M, FY19:5801401 5.8M

Annual Profit FY23:null 0.0M, FY22:-68000 -0.1M, FY21:4410356 4.4M, FY20:8185027 8.2M, FY19:5801401 5.8M

Annual Net worth FY23:-78466000 -78.5M, FY22:-84713000 -84.7M, FY21:-96171311 -96.2M, FY20:-49044477 -49.0M, FY19:-20520131 -20.5M

Quarterly Revenue Q3/2025:5000 0.0M, Q2/2025:5000 0.0M, Q1/2025:5000 0.0M, Q3/2024:5000 0.0M, Q2/2024:5000 0.0M

Quarterly Profit Q3/2025:-14955000 -15.0M, Q2/2025:5000 0.0M, Q1/2025:5000 0.0M, Q3/2024:5000 0.0M, Q2/2024:-56000 -0.1M

Quarterly Net worth Q3/2025:-19014000 -19.0M, Q2/2025:-22146000 -22.1M, Q1/2025:-19575000 -19.6M, Q3/2024:-22845000 -22.8M, Q2/2024:-24640000 -24.6M

Fund house & investment objective

Company Information Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

Organisation Biotechnology

Employees 59

Industry Biotechnology

CEO Dr. Vipin K. Garg Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow